Clinical Trial Update: Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

View source ↗

Summary

A completed genomic study investigating how genetic factors may predict the efficacy and adverse effects of the CD11a monoclonal antibody Raptiva (efalizumab) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Psoriasis | Status: COMPLETED